Trials / Completed
CompletedNCT03552653
Bioequivalence Study on Vitamin D in Healthy Adults
A Randomized, Examiner-blind Comparator-controlled Crossover Bioequivalence Study on Vitamin D in Healthy Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Church & Dwight Company, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate and compare the bioequivalence between a single oral dose of vitamin D3 gummy vitamin versus vitamin D3 tablet in healthy adults.
Detailed description
The investigators hypothesize that the gummy and tablet preparations of vitamin D3 supplement will be biologically equivalent, as defined by the absence of a statistically significant difference in bioavailability measured as blood levels of vitamin D3 after administration of the same dose of gummy and tablet supplementation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitafusion Extra Strength Vitamin D | Monitor Vitamin D blood levels |
Timeline
- Start date
- 2017-08-26
- Primary completion
- 2017-12-22
- Completion
- 2017-12-22
- First posted
- 2018-06-12
- Last updated
- 2018-06-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03552653. Inclusion in this directory is not an endorsement.